Synthesis and Biological Evaluation of some 2,5-disubstituted 1,3,4-oxadiazole based Cinnoline derivatives

 

S. Hurmath Unnissa*, Karthikaa. T, Kavitha. K, Kishore Priya. S, Kowsalya. M

Associate Professor, KMCH College of Pharmacy, Coimbatore.

*Corresponding Author E-mail: nissakmch@gmail.com

 

ABSTRACT:

Multiple drug resistance has developed due to the indiscriminate use of commercial antimicrobial drugs commonly used in the treatment of infectious diseases. In addition to this problem, antibiotics are sometimes associated with adverse effects on the host including hypersensitivity, immune suppression and allergic reaction. In order to overcome the current lacuna in the treatment of infectious diseases potential antimicrobial agents are in crucial need, therefore a Series of 3-(5-substituted-1,3,4-oxadiazol-2-yl)-6-fluoro cinnolin-4-ol were synthesized from 4-hydroxy-6-fluoro cinnoline-3-carbohydrazide. The structures of the newly synthesized compounds were confirmed by IR, NMR. All the compounds were screened for their antibacterial and antifungal activity against various pathogenic microbes. Synthesised compounds displayed very good antibacterial and antifungal activity remaining compounds showed moderate to good activity.

 

KEYWORDS: Oxadiazole, Cinnoline, antibacterial, antifungal activity.

 

 


INTRODUCTION:

Oxadiazole is a five member heterocyclic ring which is a versatile lead compound for designing potent bioactive agents. This interesting group of compound has diverse biological activities such as antimicrobial, anti-inflammatory, antitubercular, antihypertensive, analgesic, anticonvulsant, anticancer, anti-HIV, hypoglycemic and genotoxic1-5 etc.

 

Cinnoline ring6-8 is a versatile lead molecule that has been investigated widely used in medicinal chemistry due to its important pharmacological activities. This have been reported to exhibit anti-microbial, anti-tubercular, anti-malarial, anti-hypertensive, anti-convulsant, neurological disorders, anti-depressant, anti-pyretic and analgesic etc. Keeping the above facts in view, we considered it of interest to synthesize some new Series of 3-(5-substituted-1,3,4-oxadiazol-2-yl)-6 fluoro cinnolin-4-ol and have been reported as significantly active antibacterial and antifungal agent.

 

The Anti-bacterial and anti-fungal activity of all the synthesized compounds were evaluated against various microorganisms using disc diffusion method and MIC values were determined by serial dilution method.

 

MATERIAL AND METHODS:

All the chemicals were of synthetic grade and commercially procured from sigma Aldrich Chemicals. Melting points were recorded on a Buchi capillary melting point apparatus and are uncorrected. IR spectra were recorded on Fourier Transform (SHIMADZU) infrared spectrophotometer, using KBr disc method. The 1H-NMR spectra were recorded in DMSO- δ6On Perkin Elmer NMR Spectrophotometer 300MHz using TMS as an internal standard. Thin layer chromatography analyses were performed on pre-coated silica gel plates. The oxadiazole based cinnoline were synthesised as given in the following procedure9-11 and Scheme of reaction. Fig:1

 

Synthesis of 4-nitro phenyl hydrazono (cyano) acetamide:

Sodium nitrite (0.02mol) dissolved in 20ml of water was added to a suspension of 4-fluoro aniline (0.02mol) in 1N HCl (100ml). And the mixture was stirred for 1hr at 0-5şC and filtered to obtain the clear salt solution. This solution was added to the well stirred mixture of cyanoacetamide (0.02mol), ethanol (30ml) and water 400ml at 0şC. sodium acetate (100g) was then added in small portion to keep the mixture alkaline and stirred the mixture for 3 hours at 0şC. The precipitate was washed thoroughly with water, air dried and recrystallised from ethanol.

 

Synthesis of 4-amino-6-fluoro cinnoline-3- carboxamide:

A mixture of Cpd-1 (0.025mol), chlorobenzene (25mmol) and anhydrous aluminium chloride (50mmol) was stirred for 1hr and refluxed under anhydrous conditions, cooled and poured into ice and hydrochloride (25ml) was added while stirring. The residue thus obtained was washed with petroleum ether filtered and collected the filtrate and made alkaline with ammonia. The pure base was filtered and washed with DMF.

 

Synthesis of 4-hydroxy-6fluoro cinnoline-3- carboxylic acid:

5ml of 10% Sodium hydroxide was added to the Cpd-2 and add 20 ml of ethanol and heated on a water bath for 30min at 85şC. And this mixture was cooled to room temperature and added to crushed ice. The precipitate obtained was collected and washed thoroughly with water, Air dried and recrystalized from ethanol.

 

Synthesis of 4-Hydroxy-6-fluoro cinnoline-3- carbohydrazide:

Preparation of ethyl 4-hydroxy-6-fluoro cinnoline-3-carboxylate:

This Compound was synthesized by refluxing Cpd-3 (0.0587 mol) with absolute ethanol (12 ml) in presence of conc. Sulphuric acid (0.5 ml) for 5 h at 40-50°C. Excess of alcohol was distilled off and allowed to cool in ice bath.

 

Preparation of 4-hydroxy-6-fluoro cinnoline-3- carbohydrazide:

This Compounds were synthesized by refluxing a mixture of compound obtained from the above step (0.0602mol) with hydrazine hydrate (5ml) in absolute ethanol (12 ml) for 8hr at 30-40°C. The reaction mixture was cooled to room temperature and poured in ice with constant stirring.

 

Synthesis of 3-(5-substituted-1,3,4-oxadiazol-2- yl)-6-fluoro cinnolin-4-ol [OC 1-5]:

An equimolar mixture Cpd-4 (0.0054 mol) with various substituted benzoic acids (0.0054 mol) was refluxed with phosphorus oxychloride (5 ml) for 2-3hr on water bath at 100°C.Reaction mixture was cooled to room temperature and poured in ice. The precipitate obtained was filtered off, washed with water and further purified by recrystallization. The physicochemical properties are given in table:1

 

6-fluoro-3-(5-(4-nitrophenyl)--1,3,4-oxadiazol-2-yl) cinnolin- 4-ol:

Mol.form-C16H10N5O4, Mol. Wt 336.07, Yield - 72%, M.p- 165, Rf- 0.58,UVʎmax 475.0, IR(KBr,cm-1) 3181.97(OH group), 1398.14(F stretching), 1559.66(C=N stretching), 1290.14 (OH bending), 2921.63(azole moiety), 697.1(mono sub. benzene),1027.87 (N-N stretching). MS (m/z) 337

 

6-fluoro-3-[5-(p-tolyl)-1,3,4-oxadiazol-2-yl]cinnolin-4-ol:

Mol.form-C16H10N6O6, Mol.Wt-382.28, Yield-77.2%, M.p-163, Rf-0.63, UVʎmax 475.0 IR(KBr,cm-1) 3389.28(OH group), 1600.63(C=N stretching), 2922.59(azole moiety), 1393.32 (F stretching), 1011.19(N-N stretching), 1208.36(OH bending), 749.20(N-N stretching). 1HNMR(δppm) 7.25(s,1H in OHgroup), 7.45(m,2H,ArH) 7.4 (m,3H,cinnoline), 7.8(d,2H,ArH). MS (m/z) 380.0

 

6-fluoro-3-[5- (4-hydroxyphenyl)-1,3,4-oxadiazol-2-yl]cinnolin-4-ol:

Mol.form-C15H9N6O4, Mol.Wt-337.06, Yield-72.5%, M.p-157, Rf-0.67, UVʎmax 478.0 IR(KBr,cm-1) 3177.15(OHgroup), 1338.36(NO2 stretching), 1102.95(OH bending), 1646.91(C=N in Ar), 1516.74(C=C stretching), 954.31(p-subs phenyl), 2923.56(Azole moiety) 1HNMR(δppm) 9.7(s,1H,OHgroup), 7.6(d,2H in phenyl), 7.4(m,3H,cinnoline), 7.85(d,2H in phenyl). MS (m/z) 335.0

 

6-fluoro-3-[5- (4-dimethoxyphenyl)-1,3,4-oxadiazol-2-yl]cinnolin-4-ol:

Mol.form-C15H9N6O4, Mol.Wt-337.06, Yield-77% , M.p-155, Rf- 0.65, UVʎmax477.5, IR(KBr,cm-1) 3412.42(OH group), 1395.25(NO2 stretching) , 1655.59(C=N in Ar), 1596.7(C=C stretching), 2922.59 (azole moiety), 668.214(sub. Phenyl).

 

5-(4-hydroxy-6-fluoro-3-[5-(4-chlorophenyl)-1,3,4-oxadiazol-2-yl]cinnolin-4-ol:

Mol.form-C10H6N5O4, Mol.Wt-292.01, Yield-65%, M.p-187, Rf-0.58, UVʎmax 471.0, IR (KBr, cm-1) 3213.79(NH in amine), 3411.46(OH group), 1650.77(C=C in Ar), 1515.7(C=N stretching), 1399.1(NO2 stretching)


 

Fig:1. Scheme of reaction

 

Table no:1: Physicochemical parameters of synthesised compounds

compd

Molecular formula

R

Molecular weight

Percentage yield%

colour

Solubility

M. pt

Rf

Oc1

C16H8FN5O4

 

353.26

61%

Light yellow

DMSO

147˚C

0.64

Oc2

C17H11FN4O2

 

322.29

64%

Orange

DMSO

148˚C

0.62

Oc3

C16H9FN4O3

 

324.27

65%

Red

DMSO

153˚C

0.58

Oc4

C18H13FN4O4

 

368.32

67%

Light orange

DMSO

156˚C

0.68

Oc5

C16H8ClFN4O2

 

342.71

69%

yellow

DMSO

160˚C

0.66

 


Biological activity12-15

The antibacterial studies were carried out with all the synthesized oxadiazole based Cinnoline derivatives 10µg/disc against gram positive and gram negative bacteria by disc diffusion method. The MIC values of the synthesized compounds were determined. Table:2&3

 

Antifungal activity of all the synthesized compounds was evaluated against various fungal organisms. Standard Ciprofloxacin and clotrimazole discs 10µg/disc were used as standard. The MIC values of the synthesized compounds were determined. Table:4&5

 

RESULT AND DISCUSSION:

In the present study various novel 2,5 Di substituted 1,3,4-Oxadiazole derivatives were synthesized. The structure of the synthesized compounds was confirmed by IR, NMR, Mass spectral data. The IR spectrum of all the synthesized compound show characteristic absorption band at 1609.29cm-1, 3389.28 cm-1, 1582.31cm-1 arising from stretching vibration of bands (C=N,O-H,C=C respectively), 1393.21 cm-1, 749.20 cm-1 confirms the chemical structure of the compounds synthesized.

 

PMR spectra of the synthesized Oxadiazole derivatives shown aromatic protons as a multiplet in 7.0-8.0 ppm, 1 Protons of hydroxyl group appeared as a singlet at 5.0 ppm, 4 protons of aromatic group appeared as a multiplet in 6.68- 6.95 ppm. Thus the proton magnetic spectrum of the compound was in full agreement with its molecular formula, with regard to proton count and the chemical shift. The Mass Spectral analysis of the synthesized compounds performed, and the mass spectrum of the compound was in agreement with its molecular weight.

Evaluation of the results from antimicrobial studies showed the synthesized compounds with the zone of inhibition was found to be in the range of (6-20 mm) due to the presence of azole nucleus with cinnoline, fluoro and chloro group substitutions. The MIC of the synthesized compounds against was determined by serial dilution method and was found to be in the range of 1.2- 12.5μg/ml.


 

Table 2: Anti-bacterial activity of the synthesized compounds (Disc diffusion method)

Micro, organisms

Zone of Inhibition (in mm) of Compounds (10µg/disc)

OC1

OC2

OC3

OC4

OC5

Std* Ciprofloxacin

Staphylococcus aureus

17

10

10

7

6

19

Bacillus Subtilis

14

12

10

11

10

19

Escherichia coli

14

10

10

13

11

17

Salmonella typhi

11

9

10

11

7

18

 

Table 3: MIC values of the synthesized compounds (serial dilution method)

Micro

organisms

MIC values (µg/ml)

OC1

OC2

OC3

OC4

OC5

Std* Ciprofloxacin

Staphylococcus aureus

1.2

2.5

1.2

5

2.5

1.2

Bacillus subtilis

5

5

2.5

2.5

2.5

2.5

Escherichia coli

2.5

1.2

1.2

5

2.5

5

Salmonella typhi

5

2.5

5

2.5

2.5

2.5

 

Table 4: Anti-fungal activity of the synthesized compounds

Micro organisms

Zone of Inhibition (in mm) of Compounds (10µg/disc)

OC1

OC2

OC3

OC4

OC5

Std* Fluconazole

Candida albicans

16

22

16

18

17

25

Aspergillus niger

16

15

14

17

18

35

Aspergillus flavus

17

18

20

20

18

17

Saccharomyces cerevisiae

12

14

12

17

11

16

Streptomyces griseus

10

11

11

14

14

7

 

Table no :5 Antifungal MIC Values of the synthesized compounds (serial dilution method)

Micro organisms

MIC Values (µg/ml)

OC-1

OC-2

OC-3

OC-4

OC-5

Candida albicans

2.5

1.5

2.5

2.5

2.5

Aspergillus niger

2.5

2.5

2.5

3.5

2.5

Aspergillus flavus

6.25

1.25

6.25

1.25

6.25

Saccharomyces cerevisiae

12.5

3.25

12.5

3.25

12.5

Streptomyces griseus

1.2

2.5

2.5

2.5

2.5

MIC values of *Std-fluconazole-1.5µg/ml for all fungal organisms

 


CONCLUSION:

In Summary, some novel substituted Oxadiazole derivatives have been synthesized and evaluated for antibacterial and anti-fungal activity. All derivatives showed antibacterial and antifungal activity as moderate to good activity against various microorganisms. Further studies on its possible mechanism and in vivo trials in experimental animals to broaden their Pharmacological assessment, may provide a new analogue that can overcome drug resistance, prolonged treatment, complex drug regimen and side effects involved in the treatment of infectious diseases.

 

REFERENCES:

1.      Maqdoom Farooqui, Syed Nazimuddin. Synthesis of 1,3,4-Oxadiazole. Asian J. Research Chem. 2017; 10(2):154-157.

2.      Ajay Kumar K., Lokeshwari D.M., Pavithra G., Vasanth Kumar G. 1,2,4-Oxadiazoles: A potential pharmacological agents-An overview. Research J. Pharm. and Tech. 5(12): Dec. 2012; Page 1490-1496.

3.      Chhama Shukla, Sanchit Srivastav, Biologically Active Oxadiazole, Asian J. Res. Pharm. Sci. 5(4): Oct.-Dec. 2015; Page 227-233

4.      Pavlo V. Zadorozhnii, Vadym V. Kiselev et al., In Silico Prediction and Molecular Docking Studies of N-Amidoalkylated Derivatives of 1,3,4-Oxadiazole as COX-1 and COX-2 Potential Inhibitors, Research J. Pharm. and Tech 2017; 10(11): 3957-3963.

5.      Ajay Kumar K., Lokeshwari D.M., et al., 1,2,4-Oxadiazoles: A potential pharmacological agents-An overview, Research J. Pharm. and Tech. 5(12): Dec. 2012; Page 1490-1496

6.      T.V. Yuvaraj, S. Hurmath Unnissa, N. S. Surendiran, M. Azeez Ur rahman, V. Binumon. Synthesis and Antimicrobial Screening of Some Novel Cinnoline Derivatives. Asian J. Research Chem. 3(4): Oct. - Dec. 2010; Page 853-858.

7.      Shashikant B. Bhot, L.V.G. Nargund, Shachindra L. Nargund. Synthesis of Flouro cinnoline(2,3-d) pyrimidine compound for antibacterial activity. Asian J. Research Chem. 5(8): August, 2012; Page 1013-1016.

8.      Dilesh Indorkar, N. Gautam, O.P. Chourasia, S.N. Limaye. Synthesis and Characterization of Cinnoline (Benzopyridazine) and Cinnoline based Pyrazoline Derivatives and Biological Activity. Asian J. Research Chem. 6(9): September 2013; Page 832-838.

9.      Unnissa SH, Nisha N, Reddy GK. Synthesis and in Vitro Anti Microbial Evaluation Including Anti-Malarial Activity of Pyrazole Based Novel Cinnoline Derivatives. J App Pharm Sci, 2015; 5 (11): 121-126.

10.   S. Hurmath Unnissa , T. K. Ravi , Drug Design, Synthesis and Screening of Pyrazolo Cinnoline Derivatives as Potent Anti Tubercular Agent. International Journal of Pharmaceutical Research. 2015; Vol 7 (4): 80

11.   Hurmath Unnissa, S., Joseph, S., Reddy, G. K. Synthesis and in vitro antimicrobial evaluation including anti-malarial activity of some novel cinnoline derivatives. International Journal of Pharmaceutical Research, Jan – Mar 2016; 8(1): 13

12.   V Jhansipriya Marabathuni, K. Mariyamma, K. Sravani, S. Ramaiah, P. Ravindra, R. Srihari. Synthesis, Characterization, Anti Microbial, Analgesic activities of 3-(3-Chlorophenyl)-5-Phenyl-4,5-Dihydro-1,2-Oxazole Derivatives. Asian J. Pharm. Res. 2017; 7(3):171-174.

13.   Jeong-Sook Park, Jae-Hyeok Lee. Mechanism in Antibacterial Activity on Fraction of Coptidis Rhizoma against Candida Albicans. Research J. Pharm. and Tech. 2017; 10(7):2387-2390.

14.   Dibyajyoti Saha, Swati Paul, In vitro Screening of Antifungal Activity of Methanol Extract of Plumbago indica L. against some pathogenic species of fungi, Asian J. Res. Pharm. Sci. 2(2): April-June 2012; Page 55-57

15.   Maste M. M., Jeyarani P., Kalekar M. C., Bhat A. R. Synthesis and Evaluation of Benzimidazole Derivatives for Anti-tubercular and Antimicrobial Activities. Asian J. Research Chem. 4(7): July, 2011; Page 1055-1058.

 

 

 

 

 

 

 

Received on 08.05.2019           Modified on 05.06.2019

Accepted on 30.06.2019         © RJPT All right reserved

Research J. Pharm. and Tech. 2019; 12(10): 4812-4816.

DOI: 10.5958/0974-360X.2019.00832.1